Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey-Reference-Cited by-同舟云学术

Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey

Published:2016-09-30 Issue:3 Volume:123 Page:449-458
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Mesa Ruben A.¹,Miller Carole B.²,Thyne Maureen³,Mangan James⁴,Goldberger Sara⁵,Fazal Salman⁶,Ma Xiaomei⁷,Wilson Wendy⁸,Paranagama Dilan C.⁹,Dubinski David G.¹⁰,Naim Ahmad¹⁰,Parasuraman Shreekant¹⁰,Boyle John¹¹,Mascarenhas John O.¹²

Affiliation:

1. Division of Hematology and Medical Oncology; Mayo Clinic Cancer Center; Scottsdale Arizona

2. Departments of Internal Medicine and Medical Oncology; St Agnes Hospital; Baltimore Maryland

3. Department of Hematology/Medical Oncology; Weill Cornell Medical College; New York New York

4. Division of Hematology-Oncology; University of Pennsylvania; Philadelphia Pennsylvania

5. Cancer Support Community, Program Development & Delivery; New York New York

6. Division of Hematology and Cellular Therapy; Allegheny Health Network; Pittsburgh Pennsylvania

7. Department of Chronic Disease Epidemiology; Yale School of Public Health; New Haven Connecticut

8. Division of Clinical Research; Fred Hutchinson Cancer Research Center; Seattle Washington

9. Global Medical Affairs, Statistics; Incyte Corporation; Wilmington Delaware

10. US Medical Affairs; Incyte Corporation; Wilmington Delaware

11. Department of Survey Research; ICF International; Fairfax Virginia

12. Division of Hematology and Medical Oncology; Icahn School of Medicine at Mount Sinai; New York New York

Funder

Incyte Corporation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30325/fullpdf

Reference21 articles.

1. Comparison between patient-reported and clinician-observed symptoms in oncology;Xiao;Cancer Nurs,2013

2. Perception of quality of life by patients, partners and treating physicians;Wilson;Qual Life Res,2000

3. Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes;Steensma;Cancer,2014

4. Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study;Hultcrantz;J Clin Oncol,2012

5. Therapy for myeloproliferative neoplasms: when, which agent, and how?;Geyer;Blood,2014

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Myeloproliferative Neoplasms;Journal of Palliative Medicine;2024-08-20

2. Contemporary Challenges in Polycythemia Vera Management From the Perspective of Patients and Physicians;Clinical Lymphoma Myeloma and Leukemia;2024-08

3. The evolving landscape of polycythemia vera therapies;Expert Opinion on Pharmacotherapy;2024-07-23

4. Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis;Annals of Hematology;2024-04-23

5. Interferons in the treatment of myeloproliferative neoplasms;Therapeutic Advances in Hematology;2024-01